BioBoston Consulting - Regulatory Compliance in Life Sciences

BioBoston Consulting

Guidance on Common Regulations and Standards for Life Sciences

Ensure regulatory compliance with BioBoston Consulting’s expertise in 21 CFR, ICH, ISO standards, and global guidelines. Get tailored compliance solutions for life sciences.

 In the life sciences industry—whether dealing with pharmaceuticals, biologics, medical devices, cosmetics, or veterinary products—companies must adhere to a wide array of regulations and standards set by regulatory agencies such as the US FDA, EMA, ICH, and WHO. These regulations are designed to ensure the safety, efficacy, and quality of products, as well as to maintain accurate and compliant document management systems. 

BioBoston Consulting is here to help you navigate these complex regulations and ensure your company stays compliant with all necessary quality and regulatory standards. 

Understanding Common Federal Regulations (CFRs) The Thalidomide tragedy of 1962 led to the development of the Federal Food, Drug, and Cosmetic Act (21 USC), which requires all drugs to adhere to current Good Manufacturing Practices (cGMP). These practices were codified in the 21 CFR and continue to form the foundation of U.S. regulatory standards. Companies must follow these regulations to ensure product safety and efficacy. 

  1. Key 21 CFR Regulations to Know 21 CFR 11: Governs electronic records and electronic signatures, ensuring that they are as authentic as physical records. This regulation applies to any company dealing with electronic documentation that requires approval within a system. 
  1. 21 CFR 210/211: These regulations are related to cGMP for drug manufacturing, covering facilities, methods, and controls. Ensuring compliance with these standards helps meet quality and regulatory requirements. 
  1. 21 CFR Part 807, 814, 812, 801, 803: These regulations focus on medical device manufacturing, testing, and marketing. If you are manufacturing medical devices, understanding these regulations such as pre-market approvals and labeling requirements is crucial for market success. 
  • Part 807: Covers Establishment Registration and Device Listing
  • Part 814: Pertains to Pre-market Approval (PMA) for Class III devices. 
  • Part 812: Covers Investigational Device Exemptions (IDE) for clinical trials. 
  • Part 801: Describes labeling requirements for medical devices.  
  • Part 820: lists all the cGMP requirements for medical device manufacturing listed within this Part. 
  1. 21 CFR 314: Relates to the approval process for drugs and defines various applications such as New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs) for generics. 
  1. 21 CFR 600: Focuses on biological products, including vaccines, blood products, and gene therapies, providing standards for manufacturing and testing. 
  1. 21 CFR 225/226: Specifies cGMP for the veterinary drug industry, ensuring that animal feeds and medications meet safety and efficacy standards. 

International Council for Harmonisation (ICH) Guidelines

ICH Q7 – GMP for Active Pharmaceutical Ingredients (APIs) 

ISO Guidelines The International Organization for Standardization (ISO) provides critical guidelines that apply across industries, including medical devices, pharmaceuticals, and biological products. Key standards to be aware of include: 

  • ISO 13485: This standard is specific to the design and manufacture of medical devices and ensures that manufacturers maintain an effective quality management system to deliver safe and reliable products. 
  • ISO 14971: Provides a framework for risk management of medical devices, helping manufacturers identify, assess, and mitigate potential risks associated with their products. 
  • ISO 14644: Focuses on cleanroom classifications, crucial for the production of sterile products in pharmaceuticals, biologics, and medical devices. This standard ensures the cleanliness and safety of manufacturing environments. 

BioBoston Consulting helps your company understand and implement these critical ISO standards, ensuring that your products meet the highest quality benchmarks for global markets. 

How BioBoston Consulting Can Support Your Compliance Efforts 

At BioBoston Consulting, we specialize in regulatory compliance for life science industries. Our team can guide your company through the maze of 21 CFR regulations, ICH guidelines, and ISO standards, ensuring you meet every requirement efficiently and effectively. Our services include: 

  • Gap Assessments: Identify potential compliance gaps in your operations. 
  • Risk Assessment and Management: Evaluate risks related to product development, manufacturing, and testing. 
  • Mock Audits and Inspections: Prepare your company for regulatory audits with mock inspections to ensure readiness. 
  • Change Control: Implement effective change control processes to manage product lifecycle changes while maintaining compliance. 
  • Deviation and OOS Investigations: Address any deviations from standards or out-of-specification (OOS) results to ensure continued quality compliance. 
  • Regulatory Affairs: Help navigate the regulatory landscape and manage submissions to agencies such as the FDA, EMA, and WHO. 

Why Choose BioBoston Consulting for Your Regulatory Compliance Needs? 

  • Expertise in Regulatory Affairs: With deep knowledge of global standards, BioBoston Consulting can guide your organization through complex regulatory requirements. 
  • Tailored Solutions: We offer customized compliance solutions to meet the unique needs of your organization, ensuring that you stay ahead of the regulatory curve. 
  • End-to-End Support: From gap assessments to post-market surveillance, we provide comprehensive support throughout the lifecycle of your regulated products. 

Contact BioBoston Consulting to Ensure Regulatory Compliance Today 

"regulatory compliance for life sciences,

Leave a Comment

Your email address will not be published. Required fields are marked *

twenty + 20 =

Scroll to Top